These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 21172896)
1. Looking at the seemingly contradictory role of vinblastine in anaplastic large-cell lymphoma from a metronomic perspective. André N; Pasquier E; Gentet JC; Kamen BA J Clin Oncol; 2011 Feb; 29(4):e90-1; author reply e92-3. PubMed ID: 21172896 [No Abstract] [Full Text] [Related]
2. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial. Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620 [TBL] [Abstract][Full Text] [Related]
3. Long-term disease control of refractory anaplastic large cell lymphoma with vinblastine. Garner R; Li Y; Gray B; Zori R; Braylan R; Wall J; Hunger SP J Pediatr Hematol Oncol; 2009 Feb; 31(2):145-7. PubMed ID: 19194204 [TBL] [Abstract][Full Text] [Related]
4. Anaplastic large cell lymphoma presenting as hemophagocytic syndrome in an adolescent. Sovinz P; Lackner H; Schwinger W; Benesch M; Urban C; Beham-Schmid C Pediatr Blood Cancer; 2007 Dec; 49(7):1057. PubMed ID: 17941063 [No Abstract] [Full Text] [Related]
5. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial. Wrobel G; Mauguen A; Rosolen A; Reiter A; Williams D; Horibe K; Brugières L; Le Deley MC; Pediatr Blood Cancer; 2011 Jul; 56(7):1071-7. PubMed ID: 21280197 [TBL] [Abstract][Full Text] [Related]
6. Long-term survival of a child with refractory anaplastic large cell lymphoma following therapy with an antisense oligonucleotide, topotecan, and vinblastine. Wrobel G; Chaber R; Rygier J; Bonar J; Muszynska-Roslan K; Chybicka A Hematol Oncol; 2015 Mar; 33(1):52-5. PubMed ID: 21809366 [TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous anaplastic large cell lymphoma. Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005 [TBL] [Abstract][Full Text] [Related]
8. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC. Mandal S; Varma K; Jain S Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116 [No Abstract] [Full Text] [Related]
9. Successful treatment with daclizumab of refractory anaplastic lymphoma. Costa V; Oliva T; Norton L Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219 [TBL] [Abstract][Full Text] [Related]
10. [Ki-1+ large-cell anaplastic lymphoma with a leukemic appearance. Study of a case]. Rabasa P; Domingo JM; Quílez D; Monzón F Sangre (Barc); 1998 Jun; 43(3):240-3. PubMed ID: 9741234 [TBL] [Abstract][Full Text] [Related]
11. A case of anaplastic large cell lymphoma-induced hemophagocytic lymphohistiocytosis in an adolescent female. Krenova Z; Sterba J; Blatny J; Kren L; Slany J Pediatr Blood Cancer; 2007 Dec; 49(7):1056. PubMed ID: 17405157 [No Abstract] [Full Text] [Related]
12. [Anaplastic large cell lymphoma associated with tuberculoid granulomatous reaction: report of a case]. Li SM Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):124-5. PubMed ID: 16630494 [No Abstract] [Full Text] [Related]
13. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy]. Qiu H; Wang GM Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid. Chou WC; Su IJ; Tien HF; Liang DC; Wang CH; Chang YC; Cheng AL Cancer; 1996 Oct; 78(8):1805-12. PubMed ID: 8859196 [TBL] [Abstract][Full Text] [Related]